Citadel Advisors’s Intercure INCR Stock Holding History
Bought
Maintained
Sold
Other funds holding INCR
MCM
RWM
VF
AI
QC
Citadel Advisors's INCR Position: Q2 2026 in Review
Citadel Advisors reduced its Intercure (INCR) stake by 19% in Q2 2026, selling an estimated $23.1K and leaving 21,583 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #12547.
Citadel Advisors first reported a position in INCR in Q3 2021 and has held it in 20 quarters since. The position peaked at $206K in Q4 2021. 16 funds tracked by Wall St. Rank hold INCR as of Q2 2026.
- Citadel Advisors held 21,583 shares of Intercure worth $119K as of Q2 2026.
- Citadel Advisors sold 5,201 Intercure shares in Q2 2026, an estimated $23.1K.
- Intercure made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12547 holding.
- Citadel Advisors first reported a position in Intercure in Q3 2021 and has held it in 20 quarters since.
- Citadel Advisors's Intercure position peaked at $206K in Q4 2021.
- 16 funds tracked by Wall St. Rank held Intercure as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.